Health Outcome Division, College of Pharmacy, University of Texas at Austin, United States
Disclosure information not submitted.
4B-05 - Risk of respiratory and cardiovascular adverse events associated with gabapentinoid use among female breast cancer survivors in the United States: A new-user, active comparator cohort study
Monday, August 25, 20255:15 PM - 5:30 PM ET
